Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
72.1M
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
12.3M
-
Shares change
-
+5.19M
-
Total reported value, excl. options
-
$21.7M
-
Value change
-
+$9.09M
-
Number of buys
-
29
-
Number of sells
-
-12
-
Price
-
$1.77
Significant Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q1 2019
52 filings reported holding OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share as of Q1 2019.
Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.3M shares
of 72.1M outstanding shares and own 17.04% of the company stock.
Largest 10 shareholders include BVF INC/IL (3.29M shares), ARMISTICE CAPITAL, LLC (1.78M shares), COWEN INC. (1.1M shares), Redmile Group, LLC (738K shares), BlackRock Inc. (667K shares), VANGUARD GROUP INC (654K shares), Tekla Capital Management LLC (497K shares), Granite Point Capital Management, L.P. (418K shares), RENAISSANCE TECHNOLOGIES LLC (363K shares), and WELLS FARGO & COMPANY/MN (314K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.